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The William H. Beaumont Medical Research Honor Society is a research 
society of medical students that was established in 1935 to honor 
Dr. William H. Beaumont (1785–1853), a U.S. Army surgeon known as 
the “father of gastric physiology” for his groundbreaking research on 
human digestion. The organization seeks to foster a continuing interest in 
research and to promote the value of research in the practice of medicine. 
As a part of this mission, the Society integrates current research topics 
into the curriculum; publishes Fusion, a scientific journal showcasing GW 
School of Medicine and Health Sciences student research; makes available 
information on research opportunities throughout the area, including the 
William T. Gill Summer Fellowship for GW medical students; and highlights 
student and faculty research accomplishments at the annual GW Medical 
Center Research Day.
 about the society. . .
BEAUMONT 
LEADERS
Back row from left: Gena Gora, 
Jay Bhatt, Waleed Kurtom, 
Junaid Shams, and Neha 
Jakhete. Front row from left: 
Kate Serdy, Sonia Samtani, and 
Allison Spitzer. Not pictured: 
Sheliza Lalani. 
Fusion • 2010 1
Fusion is a publication of 
The George Washington 
University Medical Center’s 
William H. Beaumont 
Medical Research  
Honor Society. 
This research journal is published 
by students in collaboration with 
the Office of the Dean; Office of 
Health Research, Compliance and 
Technology Transfer; and Medical 




Provost and Vice President 
for Health Affairs
John F. Williams, M.D.,  
Ed.D., M.P.H.
Dean, School of Medicine and 
Health Sciences
James Scott, M.D., FACEP
Associate Vice President for 
Health Research




Allison B. Spitzer, M.S.II 
Kate M. Serdy, M.S.II 
Sonia R. Samtani, M.S.II
Editorial Board 
Jay Bhatt, M.S.II 
Neha Jakhete M.S.II 
Waleed Kurtom, M.S.II 
Sheliza Lalani, M.S.II 
Junaid Shams, M.S.II
Journal Club Director 





Allison B. Spitzer, M.S.II; Kate M. Serdy, M.S.II . . .  . . .  . . .  . . .  . . .  . . .  . . .  . . .  . . .  . . .  . . .  . . .  . . .  . . 3
FROM THE DEAN’S OFFICE
James Scott, M.D., Dean of the School of Medicine and Health Sciences  . . . . . . . . . . . . . . . . . . . . . . . . . 4 
FROM THE RESEARCH OFFICE
Anne Hirshfield, Ph.D., Associate Vice President for Health Research .  . . .  . . .  . . .  . . .  . . .  . . .  . . .  . . .  . . 5
BASIC SCIENCE ABSTRACTS
RNA Interference in Virus Induced Hepatitis C  
and the Silencing Mechanism of Tumor Suppressing Genes
Kulin Shah, M.S.I  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  pp. 6–7
Ethanol-Induced Apoptosis in Cultured Cells is Mediated  
by the Endoplasmic Reticulum
Andreea Balan, M.S.III . . .  . . .  . . .  . . .  . . .  . . .  . . .  . . .  . . .  . . .  . . .  . . .  . . .  . . .  . . .  . . .  . . .  pp. 7–8
Fibroblast Growth Factor Receptor (FGFR) Trafficking is Modulated by Shisa
Kate M. Serdy, M.S.II .  . . .  . . .  . . .  . . .  . . .  . . .  . . .  . . .  . . .  . . .  . . .  . . .  . . .  . . .  . . .  . . .  . . .  pp. 8–9
Macrophage Targeted Photodynamic Therapy of Inflammatory Atherosclerosis
Neha Jakhete, M.S.II .  . . .  . . .  . . .  . . .  . . .  . . .  . . .  . . .  . . .  . . .  . . .  . . .  . . .  . . .  . . .  . . .  . .  pp. 9–10
CLINICAL RESEARCH ABSTRACTS
Dynamic Stabilization for the Treatment of Degenerative Spinal Disorders  
David Goodwin, M.S.IV . . .  . . .  . . .  . . .  . . .  . . .  . . .  . . .  . . .  . . .  . . .  . . .  . . .  . . .  . . .  . . .  . . .  . .  p. 11
Incidence and Risk Factors of DVT and PE following Major Spinal Surgery
Matthew Bean, M.S.II and Todd Pierce, M.S.II  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . pp. 12–13
Outcomes of Patellar Realignment for Patellofemoral Arthritis in Young Patients
Meghan Bishop, M.S.II  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . pp. 13–14
Volumetric Analysis Reveals White Matter Volume Loss in Adults  
with Partial Ornithine Transcarbamylase Deficiency (Otcd)
Rehan Hussain, M.S.II  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  p. 15
TABLE OF CONTENTS Continued on p. 2




Variables Associated with the Acceptance of Acupuncture among Children  
with Cancer: Interim Analysis of a Prospective Study
Maria Cristina Poscablo, M.S.II .  . . .  . . .  . . .  . . .  . . .  . . .  . . .  . . .  . . .  . . .  . . .  . . .  . . .  . . .  . . pp. 16–17
Disruption of Functional Anatomy in Listening and Reading Comprehension Tasks  
in Childhood Epilepsy
Waleed Kurtom, M.S.II . . .  . . .  . . .  . . .  . . .  . . .  . . .  . . .  . . .  . . .  . . .  . . .  . . .  . . .  . . .  . . .  . . pp. 18–19
Resected Pulmonary Atypical Carcinoid and Other Bronchopulmonary 
Neuroendocrine Tumors: A Comparison of Clinical Presentation And Survival
Jay Bhatt, M.S.II  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  p. 20
Identification of Aspirin Resistant Biomarkers using Whole Blood Genome Profiling
Frederik K. Rebling, M.S.I .  . . .  . . .  . . .  . . .  . . .  . . .  . . .  . . .  . . .  . . .  . . .  . . .  . . .  . . .  . . .  .  pp. 21–22
Association of Atrogin-1 Genotypes with Baseline Muscle Phenotypes  
in Men and Women
Junaid Shams, M.S.II  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . pp. 22–23
AKT2 Gene Variants are Associated with Muscle Phenotypes  
in Both Men and Women
Allison B. Spitzer, M.S.II . .  . . .  . . .  . . .  . . .  . . .  . . .  . . .  . . .  . . .  . . .  . . .  . . .  . . .  . . .  . . .  . .  p. 24–25
HEALTH POLICY ABSTRACTS
A Needs Assessment of Internet Resource Training of Physicians in Egypt 
Nancy Maaty, MS IV  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  pp. 26–28
How Physicians Can Be Effective Injury Prevention Leaders in Gun Control 
Kam Lam, M.S.II  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  pp. 28–29
TABLE OF CONTENTS Continued from p. 1
Fusion • 2010 3
As your co-Presidents for The William H. 
Beaumont Medical Research Honor Society, we 
are proud to present you with the fourth edition 
of Fusion, GW School of Medicine and Health 
Science’s (SMHS) entirely student-run research 
journal, featuring basic science, clinical, and 
health policy research conducted by GW medical 
students. The articles span a wide variety of 
clinical specialties and scientific disciplines, from 
genetics and orthopaedic surgery to neurosurgery 
to cardiology to cancer research and therapy. This 
year we limited submissions to student research 
conducted during medical school that led to 
quantifiable scientific results, which we believe 
enhances the quality of Fusion as a student scien-
tific journal and as a reflection of the significant 
research accomplishments of GW medical stu-
dents. This is an exciting time to be conducting 
research at SMHS — with GW Medical Center 
(GWUMC) receiving major grants such as the 
Department of Microbiology, Immunology and 
Tropical Medicine’s recent $15 million grant from 
National Institutes of Health (NIH) — and we 
are excited to be representing student research at 
SMHS through the Beaumont Society.
We are pleased to have continued our Journal 
Club meetings this year, and have improved the 
format of Journal Club by taking advantage of 
a rich resource immediately at our fingertips — 
recruiting leading faculty members and specialists 
in their fields to moderate our discussions, pro-
viding valuable clinical and seasoned perspectives 
on key topics. Stay tuned for more discussions of 
current research articles this spring, led by our 
M.S.I Beaumont members!
One frequently asked question is, “What 
is Beaumont anyway?” The standard answer 
is that Beaumont is a student-run society for 
students with an enthusiasm for, and an interest 
in, research. We provide students with a forum 
to discuss current and past landmark scientific 
studies through our Journal Club, an outlet to 
share their research findings with their peers and 
the GWUMC community through publication 
in Fusion and poster presentations at Research 
Day, and a resource to learn about research 
opportunities available at GW, the NIH, and 
across the United States. The real answer, how-
ever, is that Beaumont is whatever you want it to 
be — we are always open to new ideas and sug-
gestions and we invite you to submit yours to us 
at gwbeaumont@gmail.com.
We would like to give our special thanks to 
Dean James Scott, M.D.; Dean Scott Schroth, 
M.D.; and Associate Vice President Anne 
Hirshfield, Ph.D., for their dedicated guidance 
and support as well as their innovative sugges-
tions for the improvement of the Beaumont 
Society, to our past (and future) Journal Club 
faculty moderators, Lakhmir Chawla, M.D., and 
Lisa Martin, M.D., as well as all of the faculty 
who mentored our peers during their research 
projects, as well as to Thomas Kohout for his 
hard work, patience, and positive attitude while 
assembling this year’s journal and the student 
authors and the editors of Fusion for all of their 
hard work throughout the editing process. Our 
final thanks go to Beaumont Society Vice-
President and fellow Fusion Editor-in-Chief, 
Sonia Samtani, for her work ethic, enthusiasm 
and spirit during this entire process. 
Thank you all and we hope you, the 





Co-Presidents of the William Beaumont Society
 from the editors. . .
Kate M. Serdy, M.S.II
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 from the dean’s office. . .
Congratulations to the students 
of The George Washington 
University on the research 
featured in this fourth edition 
of Fusion. A special thanks to 
Allison Spitzer, Kate Pickoff 
and Sonia Samtani as well 
as the rest of the William H. 
Beaumont Medical Research 
Honor Society for all of your 
hard work to make this journal 
possible. I would also like 
to recognize Dr. Anne N. 
Hirshfield who serves as the 
faculty advisor to the Beaumont 
Society for the encourage-
ment she gives to our students 
working in research. I would 
also acknowledge the importance of the enthu-
siasm and dedication of our scientific investiga-
tors. Finally, I’d like to acknowledge the staff 
in the Office of Student Opportunities and the 
generous supporters of that office who continue 
to make medical research attainable for many of 
our students.
In every way research is growing at the GW 
School of Medicine and Health Sciences and 
Children’s National Medical Center. We have 
major new grants in cancer, quality outcomes, 
neuroscience and tropical diseases. Our residents 
have presented and published more papers than 
ever and there are a myriad of opportunities for 
research activities by students. Scientific dis-
covery and the creation of new knowledge is the 
hallmark of any School of Medicine and Health 
Science and with this publication we recognize 
the vital and stimulating role that our students 
have in our research accomplishments. 
Fusion is a student-run publication that 
showcases the abilities of the students of the 
School of Medicine and Health Sciences. I take 
great pride in the achievements of our students 
and hope you are as impressed with their work 
as I am.
James L. Scott, M.D. 
Dean, School of Medicine and Health Sciences, 
Professor of Emergency Medicine
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 from the research office. . .
In collaboration with the students of GW’s 
William Beaumont Medical Research Honor 
Society, I am proud to present the 2010 edition 
of Fusion, the fourth volume of a publication 
created by the members of this prestigious honor 
society. The William H. Beaumont Medical 
Research Honor Society was established at the 
GW School of Medicine in 1935 to promote 
student research. 
The officers of the Society wanted to com-
municate the excitement and value of their 
experiences to you while carrying out research 
rotations, summer projects and activities that are 
preparing them for their medical careers. The 
previous editions of Fusion have been received 
with enthusiasm and, as a result, you, the wider 
audience have reaped the benefits from perusing 
the pages of this journal.
Fusion is an entirely student run publication 
that highlights the students’ abilities as prom-
ising doctors and researchers. In addition, we 
salute the faculty advisors and all those who have 
mentored and assisted in any way to make this 
publication a reality. We also need to acknowl-
edge the W.T. Gill Endowment, which on a 
yearly basis, provides stipends 
to eligible students to gain 
valuable experience in research 
during the summer months. 
As our health care system 
evolves and as new discoveries 
in medicine become evident, 
our students’ efforts now will 
prepare them for the chal-
lenges that lie ahead. I am 
honored to serve as the soci-
ety’s faculty advisor and am 
happy to support these gifted 
students in their research 
endeavors.
Anne N. Hirshfield, Ph.D. 
Associate Vice President for Health Research
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Hepatitis C, caused by the Hepatitis C Virus 
(HCV), is an infectious disease affecting the 
liver. Although asymptomatic upon acute 
infection, chronic infection can lead to liver 
cirrhosis and potential liver failure.1 With 
no vaccine currently available, an estimated 
170 million people are chronically infected 
worldwide with 3–4 million people becoming 
newly infected each year.2 
Upon infection, HCV induces precursor 
microRNA (miRNA) to develop into mature 
miRNA by interaction with the DICER 
protein, an endoribonuclease that cleaves pre-
miRNA into short, miRNA fragments. The 
mature miRNA, a double-stranded RNA 
molecule of 21–23 nucleotides, interacts with 
Ago proteins which initiate the selection of the 
complementary guide strand and catalyze its 
binding to target mRNA of hepatocyte tumor 
suppressor genes (TSGs).3 This multiprotein 
complex of Ago proteins and miRNA is known 
as a RNA-induced silencing complex (RISC).4 
RISC disrupts the tumor suppressor genes’ 
level of expression via translational function 
repression.5 The down regulation of TSGs leads 
to the uncontrolled growth of hepatocytes and 
subsequent hepatocellular cirrhosis and potential 
carcinoma. However, it is unclear exactly where 
and how RISC is formed within the cell as well 
as how the activated complex locates the mRNA 
targets.
RNA binding proteins TRBP and HuR are 
integral components in the formation of RISC. 
More specifically, these proteins are involved in 
the recruitment of other proteins such as Ago to 
the pre-miRNA/dicer complex.5 The purpose of 
our study was to discover the cellular localization 
of where these proteins originate and function 
within HCV infected cells. Such knowledge 
would provide us with more insight as to where 
RISC is formed and the mechanisms by which it 
interferes with gene expression.
Wild type hepatocytes (used as standards) 
and mutant hepatocytes infected with HCV were 
Kulin Shah, M.S.I 
Research Track, 
Advisor: Ajit Kumar, Ph.D., 
Professor of Biochemistry and 
Molecular Biology, 
The George Washington 
University School of Medicine 
and Health Sciences, 
Washington, DC.
grown separately and subsequently transfected 
with FLAG-tag TRBP and HuR proteins to 
increase their relative intracellular concentrations. 
Following incubation, a cellular fractionation 
separated the cytoplasmic, nuclear, and nucleolar 
components of the cells. A western blot using 
an anti-FLAG antibody was performed to assess 
the location in which normal and mutant cells 
were using TRBP and HuR for their biochemical 
processes. Following several trials, our results 
indicated that in both wild type and HCV 
infected cells, varying HuR concentrations were 
found throughout the cellular compartments. 
However, higher TRBP concentrations were 
encountered in the nucleolus of infected 
cells when compared to normal cells. Our 
hypothesis of RNA binding proteins, specifically 
TRBP, demonstrating increased activity in 
specific regions of the cell during infection 
was substantiated. The variability in HuR, 
however, highlights the complexity of culturing, 
transfecting, and fractionating viable hepatocytes. 
Procedural and analytical modifications to 
achieve reproducible results are currently being 
developed. Nevertheless, the preliminary results 
of this project suggest that TRBP resides mainly 
in the nucleolus upon infection and therefore, 
RISC formation and interference may occur in 
proximal vicinity. However, more research is 
needed to determine the roles these proteins play 
in RNA interference and the cellular regions 
they are most active in. Such information can 
help elucidate the complex biochemical processes 
involved in advancing Hepatitis C infection 
from an acute to chronic stage. Moreover, by 
understanding the specific interactions between 
proteins along the gene silencing cascade, steps 
can potentially be targeted and therapeutically 
knocked down to disrupt disease progression.         
REFERENCES:
1. CÃRUNTU F AND BENEA L. Acute Hepatitis C Virus 
Infection: Diagnosis, Pathogenesis, Treatment. 
Journal of Gastrointestinal and Liver Disease. 2006; 
15(3):249–56. 
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Ethanol-Induced Apoptosis in Cultured Cells 
is Mediated by the Endoplasmic Reticulum
Alcohol abuse, known for promoting cell death 
in the liver and nervous system, is a major public 
health concern.1–2 Despite significant morbidity 
and mortality resulting from alcohol, its precise 
cellular mechanism remains unknown. The 
present study investigated the sub-cellular 
mechanism of ethanol toxicity, specifically 
whether ethanol-induced apoptosis involves the 
mitochondria or endoplasmic reticulum (ER).
Ethanol induces apoptosis in cells via a 
caspase-dependent mechanism.3 Control of 
caspase activity, and thus apoptosis, is directly 
modulated by the Bcl-2 family of proteins, 
which includes both pro- and anti-apoptotic 
members.4 Anti-apoptotic Bcl-2 protects 
cells from apoptosis by inhibiting caspase 
activation, and Bcl-2 is known to be localized to 
mitochondria and the ER.5 Prior in vivo studies 
have shown that overexpression of wildtype Bcl-2 
is protective against ethanol toxicity,but it is not 
known whether protection is mediated through 
mitochondrial Bcl-2 or ER Bcl-2.6 
Chinese hamster ovary cells (CHO695) were 
transiently transfected with cDNA constructs 
encoding GFP:Bcl-2 wildtype, GFP:Bcl-2 
MAOB (mitochondria targeted) or GFP:Bcl-2 
Cb5 (ER targeted) in order to determine the 
subcellular mechanism of rescue from ethanol 
toxicity by Bcl-2. MTT assay was used to 
measure cell viability in response to a range of 
ethanol concentrations at different time points 
in naïve CHO695 cells or in CHO695 cells 
overexpressing wildtype or organelle-targeted 
Bcl-2. Cells expressing GFP alone served as 
control. Ethanol treatments of 1 M and 2.5 
M caused significant cell death at five, 10 and 
24 hours. Wildtype Bcl-2 provided significant 
rescue for CHO695 cells treated with 1 M 
ethanol at the most severe (24 hour) time 
point, but did not rescue from toxicity at 2.5 M 
ethanol. However, ER-targeted Bcl-2 provided 
significant and robust rescue at 1 M and 2.5 M. 
Interestingly, mitochondrial-targeted Bcl-2 
offered no significant protection at any ethanol 
concentration, suggesting the ER is central to the 
ethanol apoptosis mechanism.
In order to confirm these transfection data, 
and determine the sub-cellular mechanism 
of rescue from ethanol toxicity, we employed 
a peptide inhibitor approach to investigate 
whether mitochondria or ER caspases were 
responsible for ethanol-induced apoptosis. 
Caspase-9 and caspase-12 are known to be 
downstream of mitochondria and endoplasmic 
reticulum, respectively. CHO695 cells were 
treated with either a pan-caspase inhibitor, a 
caspase-9 inhibitor or a caspase-12 inhibitor 
and then treated with 1.5 M ethanol. MTT cell 
viability assay was used to measure cell viability 
in response to ethanol treatment. Untreated 
cells served as a control. Treatment with the 
pan-caspase inhibitor provided significant rescue 
from ethanol toxicity. Inhibition of caspase-12 
conferred significant protection from ethanol 
toxicity as well, while inhibition of caspase-9 did 
not provide significant rescue. These findings 
confirm our transfection data and demonstrate a 
central role for the ER in ethanol toxicity. 
In conclusion, the present study indicates 
that Bcl-2’s amelioration of ethanol toxicity is 
most likely mediated through the ER. Therefore, 
ethanol-induced apoptosis does not occur via 
a mitochondrial stress pathway and caspase-9 
activation but rather through an ER stress 
pathway and subsequent caspase-12 activation. 
Future work should clarify the role of the ER in 
ethanol toxicity.
2. HEPATITIS C, 2009. World Health Organization. www.
who.int/mediacentre/factsheets/fs164/en/index.html. 
Retrieved Oct. 20, 2009.
3. KATARZYNA J, CARMICHAEL J, AND HOBMAN T. Exploring the 
functions of RNA interference pathway proteins: 
some functions are more RISCy than others? 
Biochemical Journal. 2005; 387(3):561–71.
4. KAWAMATA T, SEITZ H, AND TOMARI Y. Structural 
determinants of miRNAs for RISC loading and 
slicer-independent unwinding. Nature Structural and 
Molecular Biology. 2009; 16:953–60.
5. CHENDRIMADA TP, ET AL. TRBP recruits the Dicer complex 
to Ago2 for microRNA processing and gene 
silencing. Nature 2005; 436:740–44.
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Fibroblast Growth Factor Receptor (FGFR) 
Trafficking is Modulated by Shisa
The requirement for mesenchymal fibroblast 
growth factor 10 (FGF10) signaling in gastroin-
testinal development has been previously demon-
strated. Through epithelial FGF receptor 2-IIIb 
(FGFR2b), a tyrosine kinase transmembrane 
receptor, FGF10 facilitates the epithelial-mesen-
chymal interaction and is necessary for proper 
development of the gut from embryonic days 
E11.5-E15.5 in mice. This mechanism is exhib-
ited in FGF10 or FGFR2b null mice that dem-
onstrate intestinal atresia in similar phenotypes. 
Defining the means by which the expression of 
FGF10 or FGFR2b are regulated may contribute 
to a more complete 
understanding of 









in the Golgi complex 
after the receptor 
is released from 
the endoplasmic 
reticulum (ER). 
Shisa is an ER 
retention molecule 
that is known to 
bind with FGFR2b, and it has been postulated 
that Shisa may modulate the membrane 
availability of FGFR2b by regulating the 
movement of the receptor from the ER to the 
Golgi complex for glycosylation. Shisa is known 
to bind with FGFR2b in the ER, but it has not 
been shown to be present in the Golgi complex.
To demonstrate Shisa expression, HeLa 
cells were transfected with mShisa-GFP and 
mCherry-ER (as an ER marker). Confocal 
microscopy was used to evaluate co-localization. 
Immunostaining was performed with affinity-
purified cation-independent mannose-6-
Kate M. Serdy, M.S.II 
Research Track 
Advisor: R. Cartland Burns, 
M.D., Associate Professor of 
Surgery, University of Pittsburgh 
Medical Center, Pittsburgh, PA.
FIGURE 1: The top three 
images confirm expression of 
mShisa in the ER.The bottom 
three images confirm that 
mShisa is also present in the 
Golgi complex.
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phosphate receptor (CI-M6PR) as a Golgi 
marker, and, co-localization was identified by 
confocal microscopy. The top three images of 
Figure 1 confirm expression of mShisa in the ER. 
The bottom three images confirm that mShisa is 
also present in the Golgi complex. 
These data demonstrate the presence of 
Shisa in both the ER and Golgi complex, 
supporting a potential role for Shisa in the 
regulation of FGFR2b maturation and therefore 
its cell surface availability. Alterations in Shisa 
expression during gut development may be 
a contributing factor to the development of 
intestinal atresia phenotypes in which the lack of 
FGF10/FGFR2b signaling has been implicated. 
REFERENCES:
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signaling for cecal development in mouse. Develop-
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International Journal of Developmental Biology. 2008; 
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Macrophage Targeted Photodynamic Therapy 
of Inflammatory Atherosclerosis
Cardiovascular disease complications such as 
myocardial infarction and stroke are leading 
causes of death worldwide.1 Atherosclerosis is 
an inflammatory vascular disease initiated by 
lipid deposition into the subendothelial space. 
Oxidation of retained lipids induces a sustained 
inflammatory response, recruiting monocytes to 
the site of injury. Monocytes differentiate into 
macrophages in an attempt to scavenge oxidized 
lipids. Unable to regress from the vascular wall, 
retained macrophages secrete pro-inflammatory 
and growth factors. Thus, the macrophage is 
critically involved in atheroma expansion and 
fibrous cap destabilization. Unstable fibrous 
caps can rupture, leading to thrombosis 
and consequent myocardial infarction or 
stroke.2, 3 Early identification and treatment of 
macrophage-rich plaques can significantly limit 
the morbidity due to atherosclerosis.
Directed therapy of inflamed atherosclerotic 
lesions is an approach to limit consequences 
of vascular disease. This study investigated 
integrated fluorescent imaging and 
photodynamic therapy (PDT) nanotechnology 
to ablate inflammatory macrophages, a well-
established therapeutic target for atherosclerosis.4 
This strategy aims to stabilize inflamed, 
macrophage-rich atherosclerotic plaques.5–7 
PDT involves injectable photosensitizers 
and subsequent light illumination to induce 
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cytotoxic singlet oxygen formation and apop-
tosis of diseased cells. Since photosensitizers are 
light-activated, PDT can be selectively applied, 
potentially reducing risk of systemic toxicity. 
Current clinical photosensitizers (i.e. chlorin) 
lack specific avidity for inflammatory cells within 
atherosclerotic lesions. To address this issue, our 
laboratory developed a macrophage-targeted 
nanoparticle (CLIO, cross-linked iron oxide) 
conjugated to a photosensitizer that targets 
plaque macrophages.5,8,9 
An in vitro assay was developed to assess 
PDT uptake and efficacy in murine macrophage-
type cells (RAW264.7) and compare the efficacy 
of CLIO-GPC (a new, more chemically efficient 
photosensitizer) to conventional photosensitizers 
and control nanoparticles.10 Two sets of cells were 
incubated with CLIO-GPC or chlorin at 37ºC 
for 90 minutes. One set of cells then underwent 
laser illumination for 5 minutes at 100 milli-
Watts power while the other set remained in the 
dark. After 24 hours, cell viability was quanti-
fied using the MTS assay to measure magnitude 
of cell death. The second part of this project 
repeated the same procedures on primary peri-
toneal murine macrophages to gauge dosing and 
potency of the agent before moving to pure in 
vivo models for testing. 
PHOTODYNAMIC THERAPY Continued on p. 10
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CLIO-GPC did not induce RAW cell 
killing as hypothesized. Free chlorin and 
CLIO-chlorin were more potent inducers of 
apoptosis (1 percent viability at 20 uM chlorin, 
15 percent  viability at 5uM chlorin) than GPC 
or CLIO-GPC. Fluorescent imaging found free 
GPC to be taken up more readily by RAW cells 
than GPC conjugated to CLIO, though no cell 
death was seen upon illumination. However, 
promising results were seen in primary peritoneal 
macrophages. While CLIO-GPC did not 
produce cell death, we did see 
cell death with free 
GPC. 
PHOTODYNAMIC THERAPY
 Continued from p. 9
atherosclerosis. These results may have important 
implications for atherosclerotic treatment via 
noninvasive (carotid artery) or catheter-based 
(coronary artery) delivery of excitation light.
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FIGURE 1: Atherosclerosis, 
by Joan Brumbaugh, M.S.II.
Lack of cell death with GPC 
could point to a problem with the 
production of free oxygen radicals when 
illuminated. More work needs to be done 
with GPC to understand its potential as a 
photosensitizer for PDT. Currently its potency 
is questionable due to reduced cell uptake. 
However, the CLIO-chlorin results are 
promising due to both high and targeted cell 
death. These in vitro results have motivated an in 
vivo study evaluating the ability of CLIO-chlorin 
to ablate plaque macrophages in experimental 
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Dynamic Stabilization for the Treatment  
of Degenerative Spinal Disorders
The field of spine 
surgery has been 
revolutionized by 
advances in tech-











fusion has been the 
gold standard for degenerative spine disease.1 
However, spinal fusion eliminates vertebral 
motion and places greater mechanical stress 
on adjacent spinal segments.2 3 As an alterna-
tive, motion-preserving technology, such as 
the Dynesys Dynamic Stabilization system has 
emerged. This device is implanted with pedicle 
screws over the posterior spine, allowing motion 
at the affected joint location, whereas standard 
fusion eliminates it. Dynamic stabilization was 
recently applied at our institution for select 
patients. This project presents the pre-operative 
and post-operative outcomes of this device. 
In this study, we reviewed charts for con-
secutive patients who received the Dynesys 
Dynamic Stabilization system for the treatment 
of degenerative spinal disorders. This retrospec-
tive review followed 17 patients for an average 
of 5.3 months. Questionnaires completed pre-
operatively and at each post-operative follow-up 
clinical exam assessed the patients’ quality of life 
and current pain levels.
Based on the 
Oswestry Low Back 




Stabilization had a 
48 percent reduction 
in pain levels from 
their pre-operative 
state. To measure 
specific regions 
of pain, we used 
the Visual Analog 
Scale. Based on this 
measure, patients 
reported a 42 percent improvement in leg pain 
and a 55 percent improvement in back pain.
The Dynesys Dynamic Stabilization tech-
nology presents a new approach to treating 
degenerative spinal disorders. It has several 
biomechanical advantages over fusion and has 
demonstrated clinical success in this cohort of 
patients.
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Orthopaedic surgery carries a significant risk 
for developing deep vein thrombi (DVT) and 
pulmonary emboli (PE) due to the associated 
bleeding and clotting. 1 Without prophylaxis, 
43 percent of post surgical spine patients will 
develop DVT.2 Pre-spinal surgery chemical 
anticoagulation is contraindicated as it has 
resulted in 0.2 percent incidence of epidural 
hematoma significant enough to require 
another operation.3,4 Pneumatic compression 
stockings reduce the combined DVT plus PE 
incidence to 0.29 percent – 3.5 percent.2,5 The 
Transforaminal/ Posteriorforaminal Lumbar 
Intrabody Fusion (TLIF/PLIF) surgical 
procedure has been shown 
to be a risk factor for the 
development of DVT and 
PE.6 Our hypothesis is that 
the incidence of DVT and PE 
is a function of patient risk 
factors and co-morbidities 
and not of the type of surgical 
procedure performed (e.g. 
TLIF/PLIF).7 Therefore, 
the purpose of this study 
is to provide a large scale 
analysis of DVT and PE 
surgical procedure risk, 
co-morbidities, and incidence. 
This project determined the incidence and 
risk factors of DVT and PE following major 
spinal surgery performed by two surgeons in 
the Department of Orthopaedic Surgery at The 
George Washington University Hospital. 
Data were obtained by retrospective chart 
review of 1,502 surgeries performed from 2001–
09. Datapoints recorded included procedure 
type, body mass index (BMI), smoking history, 
age, medical co-morbidities, DVT prophylaxis 
employed, length of stay, and any DVT risk 
factors. For the purpose of this review, DVT 
risk factors were classified as previous DVT/
PE, previous or active malignancy, the use of 
estrogen replacement therapy (ERT), and the 
use of oral contraception. We found that the 
incidence of DVT plus PE of 1.1 percent (Table 
1) was lower than that reported by Epstein of 3.5 
Incidence and Risk Factors of DVT 
and PE following Major Spinal Surgery
percent, but higher than that recorded by Nicol 
of 0.29 percent.2,5 
The following significant risk factors for 
DVT and PE are displayed in Graph 1: active 
malignancy, previous DVT/PE, ERT, discharge 
to home versus rehab, major depressive disorder 
(MDD), hypertension (HTN), renal disease, 
congestive heart failure (CHF), and benign 
prostatic hypertrophy (BPH).  
Analysis showed that the following were 
not significant risk factors: smoking, multiple 
procedures within 30 days, obesity, gender, 
GERD, hyperlipidemia, and sleep apnea. 
Contrary to Nguyen and colleagues, relative risk 
calculations for TLIF/PLIF surgery show no 
increased risk for DVT plus PE (p = 0.8).6 
As a result, the study hypothesis is not 
rejected, as TLIF/PLIF surgical procedures are 
not shown to be a significant risk factor and 
several patient risk factors and co-morbidities 
were shown to be significant. The cause of the 
difference in DVT plus PE incidence between 
Epstein, Nicol, and this study is unknown.2,5 
This study identified new risk factors: MDD, 
HTN, BPH. Increasing prophylaxis measures 
for patients with these co-morbidities may be 
indicated. Future studies are encouraged to 
look at the level of prophylaxis used on patients 
versus DVT and PE incidence. Specifically, the 
relationship of DVT plus PE incidence versus 
how many hours postoperatively chemical 
anticoagulation is administered should be 
TABLE 1:  INCIDENCE OF DVT AND PE  
FOLLOWING MAJOR SPINAL SURGERY.
 Number of surgeries analyzed for DVT/PE’s 1502
 Number of DVT counted 6
 Number of PE counted 11
 Number of DVT+PE 17
 Incidence of DVT 0.4 percent
 Incidence of PE 0.7 percent
 Incidence of combined DVT + PE 1.1 percent
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One of the most common symptoms of people 
seeking treatment from orthopedic surgeons is 
anterior knee pain associated with patellofemoral 
arthritis.1 Conservative methods to alleviate 
symptoms of patellofemoral arthritis, including 
physical therapy, bracing, or hyaluronic acid 
injections, can help relieve some of the mechan-
ical symptoms, pain, and swelling, but relief is 
often temporary.1–5 If conservative methods fail, 
there are a variety of surgical interventions for 
treatment of patellar pain and instability, but 
few target patellofemoral arthritis specifically.1–4 
Selecting the best operative method depends on 
patient age, activity level, the severity and the 
location of the chondral damage.2,3
Patellar realignment consisting of tibial 
turbercle osteotomy with anterior and medial 
transfer of the tibial tubercle (Figure 1) was 
originally described in 1983 by J.P. Fulkerson et 
Outcomes of Patellar Realignment  
for Patellofemoral Arthritis in Young Patients
al.7,8 Transferring the tibial tubercle anteriorly and 
medially aims to maintain the extensor mecha-
nism and shift the load off of the painful, degen-
erated area of cartilage.3–7 Previous studies using 
tibial tubercle anteromedialization procedures 
have described good results for the treatment of 
patellar instability and, more recently, for the 
treatment of patellofemoral arthritis in the adult 
population above 50 years old.1,3,4,6,8–10
However, the success of patellar realignment 
for the treatment of patellofemoral arthritis 
remains largely unknown, especially in the 
younger population where maintaining func-
tional ability is of primary importance.9 The 
objective of this study was to determine the 
effectiveness of patellar realignment through 
tibial tubercle anteromedialization in treating 
Meghan Bishop, M.S.II 
Advisor: Robin V. West, M.D.,  
Associate Professor of 
Orthopaedic Surgery, 
University of Pittsburgh 
Medical Center, Pittsburgh, PA.
PATELLAR REALIGNMENT Continued on p. 14
explored. In addition, future prospective 
studies might look at management of 
co-morbidities.
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GRAPH 1: Significant 
DVT/PE Risk factors after spinal 
surgery. Factors that increase 
risk are active malignancy, 
previous DVT/PE, ERT, HTN, 
MDD, renal disease, CHF, and 
BPH. Discharging the patient to 
home, versus rehab, decreases 
risk. 
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localized patellofemoral arthritis in patients under 
of 42 years of age.
Between October 2003 and October 2007, 
the tibial tubercle anteromedialization procedure 
was performed on 24 
knees (18 patients) by a 
single surgeon (R.V.W.) 
for the treatment of 
localized patellofemoral 
arthritis. Results were 
retrospectively reviewed 
at a mean 3.6 years after 
surgery. Correlations 
between age, length 
of follow-up, degree 
of chondral damage, 
and mean BMI were 
made with the IKDC 
Subjective Knee 
Evaluation Form score 
evaluated at follow-up. 
Patients’ charts and 
preoperative radiographs 
were reviewed in order 
to correlate physical exam and pre-operative 
radiographic measurements with the final results 
(Figure 2). Outcomes were determined using 
standard physical exami-
nation modalities, the 
IKDC Subjective Knee 
Evaluation Form, and 
patient-directed ques-
tions regarding satisfac-
tion with the surgery.
Patellar realignment 
was performed on 24 
knees (18 patients). 
There were fourteen 
women and four men 
with a mean age of 27.8 
years and a BMI of 29.6. 
The mean IKDC score 
was 72.8 at an average 
length of follow-up of 
3.6 years. The IKDC 
score was not signifi-
cantly associated with 
age, length of follow-up, BMI, congruence angle, 
patellar height, or grade of chondrosis. All but 
two patients (three knees) reported to be greatly 
or somewhat improved by the surgery and all 
but two patients (two knees) would undergo the 
surgery again.
This data suggests that patellar realignment 
can be performed in properly selected young 
patients with localized patellofemoral arthritis 
and can result in good outcomes. Although 
patient IKDC scores do not meet the normative 
IKDC scores for the age and gender matched 
population, the majority of patients felt that their 
condition was greatly improved with the surgery 
and would opt to have the surgery again. Patellar 
realignment through tibial tubercle anteromedi-
alization should be considered as a good option 
in treating patellofemoral arthritis in the young 
population when conservative treatments have 
failed to provide relief from pain. 
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FIGURE 2. Preoperative and postoperative Merchant 
radiographs demonstrating realignment of the patella.
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FIGURE 1. Postoperative AP and lateral radiographs 
demonstrating the position of the patella, tubercle, and 
hardware. 
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Volumetric Analysis Reveals White Matter Volume Loss in Adults 
with Partial Ornithine Transcarbamylase Deficiency (OTCD)
The urea-cycle disorders (UCDs) are a rare 
group of inborn errors of metabolism that result 
in failure to convert ammonia to urea, leading 
to hyperammonemia and substantial cognitive 
and motor deficits. Ornithine Transcarbamylase 
Deficiency (OTCD) is the most common UCD, 
with symptoms of protein intolerance and deficits 
in executive functioning, working memory, and 
motor planning. As 
ammonia crosses the 
blood-brain barrier, 
it becomes trapped 
in the brain. In order 
to buffer excess 
ammonia, astrocytes 
combine glutamate 
with ammonia to 
form glutamine via 
the enzyme glu-
tamine synthetase. 
Glutamine is not as 
toxic as ammonia, 
but is osmotically 
active in astrocytes; 
excess glutamine 
results in astrocyte 
swelling, which can lead to cerebral edema, 
increased intracranial pressure, or coma. This 
mechanism is thought to explain the white matter 
damage associated with hyperammonemia,but 
there have been no quantitative measures of white 
matter volume in this disorder.1 
The purpose of this study was to quantitate 
white matter volume (WMV) in OTCD patients 
by using a voxel-based morphometry (VBM) 
approach. VBM is a neuroimaging analysis tech-
nique that allows comparison of the local con-
centration of matter between groups of subjects, 
and it involves normalizing the images into the 
same stereotactic space.2 The hypothesis was that 
decreased WMV would be observed.
High-resolution 3D MRI data were acquired 
from 22 adult patients with partial OTCD and 
22 healthy age-matched volunteers without 
neurological impairment (Figure 1). The subject 
group included late onset males with OTCD 
as well as both asymptomatic and symptomatic 
females heterozygous for OTCD, with varying 
ages of diagnosis and metabolic control. VBM 
was performed on a PC using Matlab 7.4 and 
SPM5 software.
VBM analysis showed that OTCD patients 
have less white matter volume than age matched 
controls (p < 0.0385 False Discovery Rate). 
Depicted are the results of a two-way-t-test 
showing differences in white matter volumes. The 
colors indicate areas of decreased volume on an 
intensity scale.    
There was damage to 
the anterior limb of the 
internal capsule and the 
superior corona radiata. 
These two connected 
white matter sheets are 
important for communi-
cation between the cortex 
and subcortical structures; 
information flows from 
the thalamus through 
the internal capsule and 
corona radiata until it 
reaches the cortex. The 
corona radiata coalesces 
on to the centrum semio-
vale, the white matter 
core of the cerebral hemispheres that has been 
shown to be damaged in previous studies on 
OTCD.3 There was also white matter loss in the 
cerebellum (p <0.0385), an area known for its role 
in coordination and motor control. This could 
explain the common symptom of decreased fine 
motor control found in typical OTCD patients. 
There was diffuse white matter loss in the frontal 
cortex, the area of the brain responsible for execu-
tive function, which could explain the cognitive 
deficits seen in OTCD patients. 
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Variables Associated with the Acceptance of Acupuncture among 
Children with Cancer: Interim Analysis of a Prospective Study













FIGURE 1: Maximum MSAS Subscale Scores by Acupuncture Acceptance
*  For each subscore, the maximum score prior to acupuncture acceptance or maximum score over the total six months for 
non-acceptors was used.
The safety and feasibility of acupuncture as 
supportive care treatment for children with 
cancer has been reported previously, yet the 
reasons for using acupuncture have not been a 
specific focus of research.1–3 In this prospective 
study, variables associated with acceptance of 
acupuncture are investigated. 
This study is currently ongoing at the 
Integrative Therapies Program for Children with 
Cancer at Columbia University Medical Center. 
All acupuncture-naive patients were eligible for 
inclusion. Upon enrollment, patients or parent/
guardian completed the Memorial Symptom 
Assessment Scale (MSAS) every three weeks for 
six months.4 Patients were offered treatment with 
acupuncture or other integrative services each 
time the MSAS was completed. If acupuncture 
was accepted, a pre- and post-acupuncture 
questionnaire was administered which included 
information on reasons, expectations, and 
satisfaction with acupuncture. MSAS scores, 
physical symptom subscores, psychological 
symptom subscores, and global distress indices 
were calculated for each patient over the six 
months.
Twenty-five patients (12M/13F) were 
recruited. Patient diagnoses were leukemia/
lymphoma (15), brain tumor (4) and solid tumor 
(6). Eight patients accepted acupuncture over 
the six-month period (3M/5F; 32 percent). 
Thirty-one acupuncture and 192 non-
acupuncture treatments were administered. 
The median number of days to acceptance of 
acupuncture was 16 (Range 0–159). The median 
number of acupuncture treatments per patient 
was 2.5 (Range 1–11). Acupuncture acceptors 
were older than non-acceptors (median 15.5 
years vs. eight years, p=0.0005). The most 
prevalent symptoms (>80 percent) in acupuncture 
acceptors were cough, difficulty sleeping, pain, 
nausea, headache, changes in taste, constipation, 
and numbness/tingling. The most prevalent 
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FIGURE 1: Although all 
patients experienced similar 
therapy-related symptoms, 
children who accepted 
accupuncture had hgher 
scores on the Memorial 
Symptom Assessment Scale, 
including the Global Distress 
Index, and Physical Symptom 
subscales. 
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symptoms (>80 percent) in non-acceptors were 
pain, cough, nausea, hair loss, feelings of being 
irritable, lack of appetite, vomiting, difficulty 
sleeping, and lack of energy. Children who 
accepted acupuncture reported slightly more 
symptoms over the six-month period compared 
to children who did not (Medianacu =11.7 
vs. Mediannon-acu =8.6). When examining 
maximum MSAS scores, which take into account 
the frequency, severity, and distress of symptoms, 
we found that patients who accepted acupuncture 
had higher MSAS scores, physical symptom 
subscores, and global distress indices compared 
to non-acceptors (Figure 1). These differences 
were not statistically significant. However, similar 
trends for each subscale were seen when we 
analyzed the average MSAS scores over the entire 
study period. 
Age is an important factor in acceptance of 
acupuncture. Children who receive acupuncture 
seem to report a similar constellation of 
symptoms as children who do not receive 
acupuncture. However, children who accept 
acupuncture may experience these symptoms 
at a greater frequency, increased severity, or at 
heightened distress. Subsequent analyses with 
the entire study population will be necessary 
to validate these initial findings. Evaluation 
of variables related to the acceptance of 
acupuncture, including therapy-associated side 
effects and symptoms, may identify those patients 
likely to benefit most from acupuncture services.
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Epilepsy populations often have greater atypical 
language representation and often have (subtle) 
impairments in language functions; thus we 
aimed to look at connectivity beyond language 
dominance. The actions of listening to and 
reading stories show strong activation along the 
superior temporal sulcus, and consistent left 
laterality across ages in the inferior frontal gyrus, 
middle frontal gyrus, and posterior temporal 
regions. Cortical functional connectivity, as 
indicated by the concurrent spontaneous activity 
of spatially segregated regions, may determine 
the reaction of the brain to external stimuli and 
task requirements and appears altered in many 
neurological and psychiatric disorders.2 Just et 
al. (2004) found consistently lower functional 
connectivity grouping autism when compared 
to controls. This group’s findings suggest that 
autism affects information integration and neural 
processing.3 
Disruption of Functional Anatomy in Listening and 
Reading Comprehension Tasks in Childhood Epilepsy
There were 59 healthy controls (4–12 year-
olds) and 43 left focus localization-related epi-
lepsy patients (4–12 year-olds) evaluated using 
two fMRI language tasks (reading comprehen-
sion and listening comprehension) obtained at 
3T with EPI BOLD techniques. fMRI maps 
were interpreted at a standard threshold and lat-
erality and connectivity data was gathered using 
spm2. Healthy controls with frontal activation 
have higher laterality in the middle frontal gyrus 
(MFG) and inferior frontal gyrus (IFG) (p=.022, 
p=.062) for the listening task. These controls also 
have lower connectivity values in IFGR-IFGL 
and MFGR-MFGL than patients without frontal 
activation (p=.027, p=.062). When comparing 
LI values between patients and healthy controls, 
there are no differences in their laterality of 
language in IFG and WA but there is a trend for 
MFG variance between groups (patients n=43, 
healthy controls n=59, p=.10). Patients for the 
Waleed Kurtom, M.S.II 
 Research Track 
William D. Gaillard, M.D., 
Division Chief, Epilepsy and 
Neurophysiology and 
Director, Comprehensive 
Pediatric Epilepsy Program, 
Children’s National Medical 

















































ANATOMICAL CONNECTIVITY N VS. P LISTENING (N=59, N=43)
FIGURE 1: Relationship
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listening task show stronger connectivity values 
than healthy controls in IFGR-IFGL, WAL-
IFGL, MFGR-MFGL, and WAR-WAL (p<.01) 
(Figure 1). In our patient population and healthy 
control group, connectivity values did not vary 
by age. 
Patients for the reading task have more 
atypical language representation in MFG and 
WA than healthy controls (p=.015, p=.016) and 
overall more atypical language representation in 
all areas (p=.021). There were no connectivity 
differences between healthy subjects and patients 
in IFGR-IFGL, WAL-IFGL, and MFGR-
MFGL; for WAR-WAL, there are stronger 
connectivity values in patients than in controls 
(p<.001). 
Our reading comprehension task was tar-
geted to identify dominant middle temporal 
gyrus and superior temporal gyrus in addition 
to dominant IFG and MFG. Our listening task 
was targeted to identify temporal receptive cortex 
regions along the dominant superior temporal 
sulcus.4 Further progression of this project will 
include group activation maps created from our 
patients while they performed these tasks to see 
if they have activation patterns consistent with 
these studies’ findings; a comparison between 
these group maps and the healthy control group 
maps (Figure 2) would be of interest in estab-
lishing whether or not left-focus epilepsy affects 
the strength of activation in these areas. Our 
research has found that connectivity is similar 
between patients and controls, with some modest 
differences that may relate to working memory 
issues. Our next step is to look at connectivity 
differences between patients with typical and 
atypical language representation.
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FIGURE 2: Group 
Activation Maps for our healthy 
control group.
Fusion • 201020
Resected Pulmonary Atypical Carcinoid and Other 
Bronchopulmonary Neuroendocrine Tumors: A 
Comparison of Clinical Presentation and Survival
Pulmonary atypical carcinoid (AC) and typical 
carcinoid (TC) tumors are in the bronchopul-
monary neuroendocrine tumor (BPNET) clas-
sification that includes large-cell neuroendocrine 
carcinoma (LCNEC), and small cell lung cancer 
(SCLC).1 Previous small scale studies suggest 
that resected pulmonary AC has a clinical pre-
sentation and survival pattern distinct from TC. 
We reviewed a large epidemiologic cancer data-
base, and hypothesized: 1) resected pulmonary 
TC will show a favorable clinical presentation 
and survival pattern, 2) resected AC will show a 
clinical presentation and survival pattern similar 
to LCNEC and 3) resected SCLC will demon-
strate the least favorable clinical presentation and 
survival pattern. 
The Surveillance Epidemiology and End 
Result database was queried to compare demo-
graphic (age, gender, ethnicity) and tumor 
specific clinical variables (including nodal status 
and stage) in 2239 patients diagnosed with, and 
undergoing lobectomy for TC, 145 patents with 
AC, 510 patients with LCNEC and 1521 patients 
with SCLC from 2001 to 2006. We performed 
univariate analysis of clinical variables and 
analysis of survival among the BPNET histologic 
types. 
AC patients presented at a similar age of diag-
nosis (Mean 59.9 years) as TC patients (Mean 
age 58.5) but younger than LCNE and SCLC 
patients (Mean age of 65.3 and 66.2 respectively, 
P < 0.001). AC and TC had higher predilec-
tion towards female patients (70.3 percent and 
68.7 percent) than LCNE and SCLC (45.7 
percent and 51.4 percent, p < 0.001). All BPNET 
patients had a statistically equal predilection to 
white ethnicity. AC patients had greater inci-
dence of histologically positive lymph nodes and 
higher pathologic stage compared to TC, similar 
to LNEC but more favorable than SCLC (p < 
0.001). Survival analysis showed a step wise mean 
survival of 40.0 ± 1.9 months for SCLC, 46.2 ± 
2.2 months for LCNEC, 58.3 ± 2.5 months for 
AC tumors, 

















that exhibit clinical behavior distinct from AC 
and LCNEC. Atypical carcinoid tumors should 
be staged and treated with stage appropriate 
neoadjuvant and adjuvant therapeutic strategies 
similar to LCNE and other non-small cell lung 
cancers. 
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Cardiovascular disease (CVD) is the leading 
cause of death in the industrial world, where 
one in three adults are diagnosed with CVD.1 
Acute coronary syndromes alone account for 
30 percent of all deaths in the U.S. each year.2 
Atherosclerotic plaque formation and rupture 
accounts for the majority of acute coronary 
syndromes, as these trigger platelet aggregation 
leading to arterial occlusion. The most com-
monly prescribed inhibitor of platelet aggrega-
tion is acetylsalicylic acid, commonly known 
as aspirin. The effectiveness of aspirin has been 
questioned in past years. Clinical studies revealed 
that as many as 20 percent of patients taking 
aspirin have recurrent ischemic vascular events, 
suggesting that aspirin may be ineffective for 
some people. These clinical findings inspired 
the term aspirin resistance (AR). The underlying 
causes of AR are unknown, and few clinical 
studies attempt to describe them. Some attribute 
AR to an inadequate dosage of aspirin, patient 
non-compliance, difference in absorption, or 
genetic causes.3 Our research study attempts 
to identify possible biomarkers, which could 
be used to diagnose patients as AR via genetic 
profiling.
Aspirin resistance is measured using the 
Verifynow® System. 
Patients with 550 
Aspirin Reaction Units 
(ARU) or more are 
considered AR, while 
patients below 550 
ARU are considered 
aspirin-sensitive. Gene 
expression profiling 
was conducted on 
eight aspirin-sensitive 
(424 ARU ± 37 σ) 
and eight resistant 
patients (568 ARU 
± 15.4 σ) via the 
Affymetrix HG-U133 
2.0 GeneChip arrays. 
Using GeneSpring 
10.0, genes satisfying 
two parameters, 
P-value (≤ 0.05) and 
FIGURE 1: Functional relationships of differentially 
expressed genes in AR patients and known contributors of 
cell adhesion.
 CNR1 = Cannabinoid Receptor-1, 
ICAM1 = Intercellular 
Adhesion Molecule-1, 
ITGAM = Integrin Alpha-M, 
PECAM1 = Platelet/
endothelial cell 
adhesion molecule 1, 
PTGES = prostaglandin E 
synthase, SPP1 = secreted 
phosphoprotein-1, 
THBS1 =  thrombospondin-1, 
VCAM1 = vascular cell adhesion 
molecule-1, VWF = von Willebrand factor.
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fold change (FC ≥1.8, 2.0), were calculated and 
then considered for further analysis and assays 
using Pathway Studio 6.1 and Ingenuity Pathway 
Analysis (IPA).
The gene expression profile indicated that 
284 genes (p ≤ 0.05, FC ≥ 1.8) were differentially 
expressed, of which 61 genes were strongly differ-
entially expressed (FC ≥ 2.0). Notably, pathway 
analysis (Figure 1) revealed that prostaglandin 
E synthase (PGES, FC= +3.62) and thrombos-
pondin-1 (THBS1, FC = -2.17) are closely related 
to cell adhesion.
In search of potential biomarkers for AR, 
gene expression profiling of AR patients revealed 
that PGES is significantly upregulated. PGES 
synthesizes PGE2, a metabolite downstream of 
COX that causes both pro- and anti-coagulation 
effects downstream upon release from activated 
platelets as a function of its concentration. 
Membrane-bound PGES synthesizes PGE2 
from [PG]H2 derived from COX-1 and a related 
enzyme, COX-2.4 The COX-2/PGES pathway is 
resistant to aspirin and could represent an alter-
native route to blood coagulation.
ASPIRIN Continued on p. 22
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Another potential biomarker of interest is 
THBS1 due to its close functional relationship 
with von Willibrand Factor (vWF). vWF is 
a multimeric protein that promotes adhesion 
of platelets to sites of vascular injury. THBS1 
inhibits blood coagulation by decreasing vWF 
multimer size.5 Our gene expression profile 
indicates that THBS1 is significantly down-
regulated, which suggests that vWF has a higher 
hemostatic competence in AR patients.
Patients resistant to aspirin remain unknow-
ingly at risk for sudden cardiovascular events. 
Our gene expression profiling identified several 
promising pathways that could explain the 
aspirin resistance phenotype. Further investiga-
tion will be required to determine the contribu-
tion of these pathways to aspirin resistance.
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The maintenance of muscle mass is regulated by 
a balance between protein synthesis and protein 
degradation pathways; a balance shifted toward 
protein degradation during atrophy. Muscle 
atrophy occurs as a consequence of various 
conditions, such as aging, bed rest, cancer, 
denervation, injury, and joint immobilization. 
The increased proteolysis in atrophying muscles 
results from the activation of the ATP-dependent 
ubiquitin proteasome proteolysis pathway.
Atrogin-1 is an ubiquitin-protein ligase (E3) 
that is a critical component of the ubiquitin-
proteasome pathway (Figure 1), expressed 
specifically in striated (cardiac and skeletal) 
muscle. It directs the breakdown of muscle 
protein in response to various conditions (ex. 
disuse, cancer, starvation), and it is down-
regulated during the hypertrophy response. 
As a result, Atrogin-1 has strong potential as a 
modifier of muscle size and strength. Examining 
genetic variation in the Atrogin-1 gene may help 
explain inter-individual differences in muscle 
size and strength, as well as differences in the 
response to resistance training.
Seven hundred fifty-eight Caucasian college-
aged subjects (446 females; 312 males; age 24 ± 8 
y) participated in a 12 week supervised strength 
training program for the upper arm muscles 
(biceps and triceps). The program consisted 
of two 45–60 minute sessions per week for 12 
weeks, as each session was supervised by an 
exercise physiologist professional or a trained 
student. Muscle size (via MRI) and strength 
measurements (1 RM and isometric) were taken 
before and after training. The study participants 
were then genotyped for five Atrogin-1 
Single Nucleotide Polymorphisms (SNPs); 
rs4871385, rs6990663, rs3739287, rs2891779, 
and rs16898553. A list of the SNPs that were 
genotyped and their positions in the Atrogin-1 
gene can be found in Table 1. Genotyping for 
the Atrogin-1 SNPs was performed using the 
TaqMan allele discrimination assay. Associations 
between the SNP and each phenotype were 
tested using ANCOVA with Sidak post-hoc tests. 
Significant associations between Atrogin-1 
SNPs and several muscle phenotypes were 
found. The most significant results were found 
in females with the rs2891779 SNP, which is 
located in the promoter region of the Atrogin-1 
gene. Specifically, when a dominant model was 
applied, females having one or two copies of 
the A allele had significantly higher baseline 
isometric strength, torque, and muscle quality 
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than those who were homozygous for the G 
allele. These same associations were seen in both 
the dominant and non-dominant arms. 
This data suggests that the Atrogin-1 
rs2891779 SNP influences baseline muscle 
strength, torque, and muscle quality in females, 
which may indicate a sex-
specific effect for this SNP. 
The location of this SNP 
in the promoter region of 
Atrogin-1 suggests that 
it may exert its influence 
through regulation of 
Atrogin-1 expression. This 
data contributes additional 
insight to the complex 
genetic milieu that affects muscle size and 
strength.
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FIGURE 1: Atrophy and Hypertrophy pathways
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Phenotype Gender AKT2 AKT2 AKT2 AKT2
   (rs7254617) (rs892118) (rs2304186) (rs969531)
 Baseline 1-RM strength Female 1.02; NS 1.62; NS 0.46; NS 0.07; NS
 Difference in 1-RM strength Female 2.18; NS 1.66; NS 0.42; NS 0.43; NS
 % change in 1-RM strength Female 2.11; NS 2.38; NS 1.16; NS 1.01; NS
 Baseline isometric strength Female 0.45; NS 1.23; NS 0.27; NS 0.16; NS
 Difference in isometric strength Female 0.11; NS 0.51; NS 0.36; NS 5.33; 0.0051
 % change in isometric strength Female 0.22; NS 0.52; NS 0.13; NS 3.95; 0.0198
 Baseline whole muscle volume Female 1.32; NS 0.61; NS 0.54; NS 0.69; NS
 Difference in whole muscle volume Female 0.31; NS 0.21; NS 0.20; NS 0.24; NS
 Baseline 1-RM strength Male 0.24; NS 0.09; NS 5.17; 0.0062 0.28; NS
 Difference in 1-RM strength Male 0.11; NS 0.12; NS 4.20; 0.0160 0.46; NS
 % change in 1-RM strength Male 0.36; NS 0.52; NS 6.87; 0.0012 0.14; NS
 Baseline isometric strength Male 0.28; NS 0.07; NS 0.10; NS 0.52; NS
 Difference in isometric strength Male 0.48; NS 0.15; NS 3.38; 0.0353 0.57; NS
 % change in isometric strength Male 0.09; NS 0.15; NS 1.69; NS 0.46; NS
 Baseline whole muscle volume Male 1.90; NS 0.33; NS 0.98; NS 0.31; NS
 Difference in whole muscle volume Male 1.43; NS 3.43; 0.0345 3.23; 0.0418 0.49; NS
 * All models adjusted for age & baseline body mass
 ** Significance level is 0.0062 after correction for multiple testing.
TABLE 1. ANALYSIS OF AKT2 SNPS WITH 1-RM STRENGTH, ISOMETRIC 
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The purpose of this study was to examine 
whether AKT2 Single Nucleotide Polymorphisms 
(SNPs), were associated with muscle strength and 
size phenotypes and responsiveness to resistance 
training in men and women. The gene vari-
ants tested were: rs2304186 (3’ UTR regulatory 
region), rs969531 (5’ UTR regulatory region), 
and rs892118 (intronic region). 
The AKT serine/threonine kinase is involved 
in various important cellular events such as cell 
survival, proliferation and differentiation, as 
well as insulin-stimulated glucose metabolism 
and cellular protein synthesis.1,2 Activation 
of AKT is essential for cell survival during 
myogenesis, and consequently AKT activity 
increases during myogenesis.3 Several studies 
have demonstrated that expression of the AKT2 
isoform in particular is significantly elevated 
during skeletal muscle differentiation.2,4,5,6 
Since AKT2 is activated by exercise and muscle 
contraction in both rodents and humans, it is an 
attractive target gene for studying human skeletal 
muscle size and function pre- and post-resistance 
training.7
In this prospective genome-wide association 
study, 753 Caucasian subjects (449 female, 304 
male) [from the FAMUSS cohort] were enrolled 
in a resistance-training program. The phenotypes 
being measured included muscle strength and 
muscle and fat volume. All phenotype measures 
were examined before and after a 12-week 
training program. For each SNP, a Chi-square 
analysis was used to test Hardy-Weinberg equilib-
rium. Associations between each SNP and phe-
notype measure were tested with Sidak post-hoc 
tests. Each model included baseline body weight 
and age as covariates and used a dominant genetic 
model.
We found that the AKT2 rs2304186 variant 
was significantly associated with baseline subcu-
taneous fat in males only (Table 2). Males with a 
copy of the T allele demonstrated a significantly 
AKT2 VARIANTS Continued on p. 25
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SNP Phenotype Gender F-test P-value N; adjusted mean ± SEM P-value for
       signifi cantly
       different means
 AKT2 Difference in Male 3.43 0.0345 CC (N=117; 70634 ± 4053) NONE
 (rs892118) whole muscle     CT (N=52; 86995 ± 6083)
  volume    TT (N=8; 97639 ± 15501)
 AKT2 Baseline Male 5.17 0.0062 GG (N=112; 27.66 ± 0.54) *p=0.0051
 (rs2304186)  1-RM strength    GT (N=141; 26.43 ± 0.48)*
      TT (N=67; 29.13 ± 0.70)*
 AKT2 Difference in Male 4.20 0.0160 GG (N=104; 10.14 ± 0.48) *p=0.0122
 (rs2304186) 1-RM strength     GT (N=124; 10.97 ± 0.44)*
      TT (N=60; 8.72 ± 0.64)*
 AKT2 % change in Male 6.87 0.0012 GG (N=104; 38.80 ± 2.03) *p=0.0009
 (rs2304186) 1-RM strength    GT (N=124; 44.11 ± 1.85)*
      TT (N=60; 32.14 ± 2.68)*
 AKT2 Difference in Male 3.38 0.0353 GG (N=103; 19.69 ± 2.02) NONE
 (rs2304186)  isometric strength     GT (N=123; 26.06 ± 1.85)
      TT (N=60; 19.62 ± 2.66)
 AKT2 Difference in Male 3.32 0.0418 GG (N=63; 81718 ± 5505)* *p=0.0481
 (rs2304186)  whole muscle    GT (N=81; 78605 ± 4857)
  volume     TT (N=37; 59775 ± 7185)*
 AKT2 Difference in Female 5.33 0.0051 GG (N=211; 12.31 ± 0.94)* *p=0.0054
 (rs969531) isometric strength     GA (N=208; 14.58 ± 0.95)
      AA (N=34; 20.26 ± 2.35)*
 AKT2 % change in Female 3.95 0.0198 GG (N=211; 21.90 ± 1.71)* *p=0.0256
 (rs969531) isometric strength     GA (N=208; 25.90 ± 1.73)
      AA (N=34; 34.04 ± 4.28)*
TABLE 2. SIGNIFICANT ASSOCIATIONS:
greater mean baseline 
subcutaneous fat 
volume (p=0.0243) 
than males that were 
homozygous for the 
G allele (Table 1). No 
signifi cant difference 
in strength or volume 
was found in females.
The AKT2 
rs969531 variant 
was signifi cantly 
associated with dif-
ference in isometric 
strength (p=0.0212) 
and the percent 
change in isometric 
strength (p=0.0288) 
in females, but not 
in males (Table 2). 
Females who had a 
copy of the G allele 
demonstrated a 
signifi cantly greater 
percent change in 
isometric strength 
than females that 
were homozygous for 
the A allele (Table 1). 
The AKT2 rs892118 variant was shown to 
be signifi cantly associated with the difference in 
whole muscle volume (p=0.0098) and subcuta-
neous fat volume (p=0.0187) in males (Table 2).
These data suggest that AKT2 genotypes have 
a sex-specifi c effect on baseline values of fat in the 
human arm. Further, AKT2 gene variants play 
a signifi cant role in increases in muscle strength 
and size. Further applications of this study will 
include testing other data sets with similar phe-
notypes as well as complete functional studies of 
these AKT2 SNP’s in skeletal muscle cells.
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An essential part of medical education is the use 
of evidence-based medicine. In April 2009, I 
participated in a medical mission to Egypt with 
Hands Along the Nile Development Services 
(HANDS), facilitated by local partner organiza-
tion Coptic Evangelical Organization for Social 
Services (CEOSS), where we held three work-
shops on navigating through the PubMed MeSH 
database for 35 physicians in El Minia and Cairo. 
PubMed was chosen due to its reliability, accessi-
bility, and because it is free of charge. In previous 
missions, Egyptian physicians voiced a need for 
internet training, however their level of experi-
ence with internet search engines was unclear. 
Therefore, we decided that this would be an 
appropriate time to conduct a needs assessment. 
During each session we administered a pre-test 
consisting of 15 questions and a post-test con-
sisting of 11 questions to help assess the relevance 
of our presentation to the physicians. There were, 
however, limitations of the data collected from 
A Needs Assessment of Internet  
Resource Training of Physicians in Egypt
the pre- and post-tests, including small sample 
size, late-comers resulting in more post-test than 
pre-test responders, and possible misinterpretation 
of the questions which may explain discrepancy 
in the data (for example, only 5 of 25 responders 
stated that they have heard of PubMed, while 7 
of 25 stated they had used the database at least 
weekly).
Each session began with a power-point pre-
sentation providing a step-by-step approach to 
navigating the MeSH database. The remainder of 
the session involved the participants formulating 
several questions, using the PICO format, which 
were then used to search for evidence-based litera-
ture through MeSH. PICO is a way of focusing 
and individualizing a clinical question in order 
to facilitate a search for relevant evidence-based 
information. The structure includes: 
1.  “P” for patient information/characteris-
tics or problem; 
2.  “I” for interventions, exposures or factors 
 health policy issues. . .
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GRAPH 2:  How much training have you had in using internet resources (in general)? How many hours of training have 
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that may influence a 
prognosis; 
3.  “C” for comparison if 
applicable; and 
4.  “O” for outcome as it is 
manifested as a change 
in symptoms, adverse 
reactions, function or 
scoring.
Based on information 
collected from the pre-test, 
eight of 25 responders 
had previous training in 
PubMed [Graph 2], while 
7 of 24 had indicated that 
they have used PubMed at 
least once a week to search 
for medically-relevant 
information [Graph 1]. 
Although 8 of 20 (40 per-
cent) pre-test responders 
felt very comfortable in 
using PubMed, none felt 
comfortable enough to 
train others [Graph 4]. 
By the end of the session, the comfort levels 
were increased with 20 of 34 (59%) post-test 
responders indicating that they felt “very com-
fortable” using MeSH, and with 4 of 34 indi-
cating that they were now “comfortable enough 
to train others” in the use of PubMed [Graph 
4]. Their increasing comfort was also apparent 
throughout the session as the physicians grew 
more involved and with many eagerly volun-
teering to lead different search inquiries. One 
doctor indicated that “before I depended on my 
kids to show me how to deal with the net, but 
now I can [do it on my own].” 
RESOURCE TRAINING Continued on p. 28
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How Physicians Can Be Effective  
Injury Prevention Leaders in Gun Safety
Historically, physicians have been involved with 
injury prevention, such as car safety devices and 
smoking cessation. Homicide due to firearm 
injury is the second leading cause of death in 
the 10–24 age group.1 In fact, homicide of a 
household member is three times more likely and 
suicide risk increases by five times in homes with 
guns than in homes without guns.2 Medical soci-
eties, such as the American College of Physicians, 
the American Academy of Pediatricians, and the 
American Medical Society all support the safe 
storage of guns.3 
Out of all health care providers in the United 
States, pediatricians have the most access to par-
ents.1 Barkin et al. states that, “because families 
must bring their children in for routine medical 
examinations before the children can attend first 
grade, health professionals have a unique oppor-
tunity for early intervention before gun injury, 
unintentional or intentional, manifests itself.”4 
Naureckas et al. found that 25 percent of chil-
dren between the ages of three and four could 
pull a trigger of a gun.5 Jackman et al. found that 
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76 percent of boys who encounter a gun in a safe 
environment would handle the gun and 48 per-
cent would pull the trigger.6 Due to the high risk 
of mortality from gun violence in children and 
the decimating impact that death has on loved 
ones, physicians can play vital roles in health 
prevention and gun safety.
While most pediatricians believe it is impor-
tant to counsel patients about gun safety, less 
than half of them do.4 There are many sur-
mountable barriers to firearm safety counseling, 
such as a lack of awareness and prioritization 
of the issue, insufficient physician knowledge 
or training, low confidence in the effectiveness 
counseling, and physician time constraints. 
Barkin et al. found that “significant positive asso-
ciations [with firearm safety counseling include] 
younger clinician age, female sex, household 
handgun ownership status, and the perception 
that firearm safety counseling is beneficial.”4 
Likewise, Cheng et al. found that “the primary 
predictors of physician counseling [are] an issue’s 





































GRAPH 4: How comfortable are you in using the internet/pubmed to find an evidence-based article?
Although the main objective of this presenta-
tion was to provide training, we were pleased to 
find that the physicians were extremely recep-
tive to the material, and that many had taken 
on a leadership role during the sessions. Some 
physicians were now able to help their colleagues 
navigate through the search engine without need 
for any further assistance. Having resources, other 
than google, to search for evidence-based litera-
ture will allow these doctors to not only update 
their practices, but will also promote the utiliza-
tion of evidence-based medicine as they continue 
to pass this information on to their colleagues. 
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and perceived effectiveness of counseling, while 
concerns about time and reimbursement were 
secondary.”7 Residents [are] more likely to dis-
cuss injury prevention and less likely to perceive 
a barrier if their attending physicians placed 
importance on this issue.8 Most patients agree 
that physicians can influence public opinion, but 
much fewer think that physicians are knowledge-
able in gun safety counseling.9,10 Even though 
physicians cite several barriers to injury preven-
tion counseling, patients have confidence in 
physicians’ abilities to change public opinion and 
consequently, these obstacles can be overcome 
with the following proposed solutions.11 
Recommendations for decreasing unin-
tentional injury and death due to guns can be 
prevented with physician involvement in firearm 
safety counseling. Cheng et al. stated that “pre-
ventive medicine training at all levels, which 
improves counseling skills and self-efficacy, [is] 
needed for physicians to attempt counseling and 
gain experience and confidence.”7 First, increased 
physician education and exposure to injury pre-
vention training throughout medical school and 
residency may reinforce the importance of this 
issue and thus remove several barriers to firearm 
safety counseling. Second, primary care and 
pediatric residency programs can teach residents 
basic information about gun safety and how 
to research educational information for their 
patients. Third, physicians can also promote gun 
safety non-verbally by placing informative bro-
chures in waiting rooms and including questions 
about gun ownership, exposure, and storage on 
patient intake forms filled out at each office visit. 
Everett et al. stated that “interventions aimed at 
increasing general health promotion activities by 
physicians [are] successful in increasing physician 
counseling and [result] in positive changes in 
their patients’ health behaviors…and psycho-
logical health.”11 By coupling physician training 
with patient education, positive public health 
implications can be achieved. 
Previous literature has stated that “the status 
of physicians’ perceptions regarding their ability 
to impact patients regarding firearm safety is 
where physicians’ perceptions of counseling 
patients regarding smoking were 25 years ago. 
The growing crisis in firearm related mor-
bidity and mortality cannot wait another 25 
years before the clinical community becomes 
involved as change agents.”11 Not too long ago, 
physicians also championed the use of seat belts 
in cars, thereby decreasing motor vehicle mor-
talities. Their role as advocates of gun safety is 
an example of another important public health 
reform issue with great potential for positive 
results, which should be addressed now in the 
midst of our ongoing health care reform. 
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